Skip to main content

CITADEL ADVISORS LLC

Position in DBVT — DBV Technologies S.A.

CIK 1423053 MIAMI, FL

Position in DBVT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$373,624
-$2,408,498 QoQ
Shares Held
22,782
-84.3% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 78 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DBVT Over Time

Shares Held

Position Value (USD)

Derivatives in DBVT

reported options exposure · as of Sep 30, 2022
CallValue
$20,886
CallShares
5,900
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,839,618 across 436 Biotechnology names. DBVT ranks #283 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DBVT

Export CSV
30 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $373,624 22,782
2025-12-31 $2,782,122 145,129
2025-09-30 $220,490 22,049
2025-04-07 $68,404,156 9,194,107
2024-09-30 $24,127 34,468
2024-06-30 $48,946 61,107
2024-03-31 $113,862 152,019
2023-12-31 $155,668 163,346
2023-09-30 $116,259 85,485
2023-06-30 $54,911 28,901
2022-09-30 $20,886 11,800
2022-06-30 $63,240 24,800
2022-03-31 $19,239 12,100
2021-12-31 $22,720 14,200
2021-09-30 $99,381 20,282
2021-06-30 $180,726 33,100
2021-06-30 $119,202 21,832
2021-06-30 $54,600 10,000
2021-03-31 $213,200 40,000
2021-03-31 $103,423 19,404
2020-12-31 $44,278 16,900
2020-12-31 $42,082 16,062
2020-12-31 $74,932 28,600
2020-09-30 $61,761 35,700
2020-06-30 $47,412 10,800
2020-06-30 $2,377,781 541,636
2020-06-30 $96,580 22,000
2020-03-31 $90,160 23,000
2020-03-31 $168,560 43,000
2020-03-31 $3,767,907 961,201